Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla.
Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York.
JAMA Ophthalmol. 2023 Apr 1;141(4):349-356. doi: 10.1001/jamaophthalmol.2023.0005.
In eyes with suspected glaucoma, it is clinically relevant to find diagnostic tests for the risk of development of perimetric glaucoma.
To investigate the association between rates of ganglion cell/inner plexiform layer (GCIPL) and circumpapillary retinal nerve fiber layer (cpRNFL) thinning and the development of perimetric glaucoma in eyes with suspected glaucoma.
DESIGN, SETTING, AND PARTICIPANTS: This observational cohort study used data collected in December 2021 from a tertiary center study and a multicenter study. Participants with suspected glaucoma were followed up for 3.1 years. The study was designed in December 2021 and finalized in August 2022.
Development of perimetric glaucoma was defined as having 3 consecutive results showing abnormal visual fields. Using linear mixed-effect models, rates of GCIPL were compared between eyes with suspected glaucoma that did and did not develop perimetric glaucoma. A joint longitudinal multivariable survival model was used to investigate the performance of rates of GCIPL and cpRNFL thinning in predicting the risk of developing perimetric glaucoma.
Rates of GCIPL thinning and hazard ratio (HR) of developing perimetric glaucoma.
Among a total of 462 participants, the mean (SD) age was 63.3 (11.1) years, and 275 patients (60%) were female. Of 658 eyes, 153 eyes (23%) developed perimetric glaucoma. The mean rates of GCIPL thinning were faster in eyes that developed perimetric glaucoma (-1.28 vs -0.66 μm/y for minimum GCIPL thinning; difference, -0.62; 95% CI, -1.07 to -0.16; P = .02). Based on the joint longitudinal survival model, every 1-μm/y faster rate of minimum GCIPL and rate of global cpRNFL thinning were associated with a 2.4 and 1.9 higher risk of developing perimetric glaucoma, respectively (HR, 2.4; 95% CI, 1.8 to 3.2, and HR, 1.99; 95% CI, 1.76 to 2.22, respectively; P < .001). Among the predictive factors, African American race (HR, 1.56; 95% CI, 1.05 to 2.34; P = .02), male sex (HR, 1.47; 95% CI, 1.02 to 2.15; P = .03), 1-dB higher baseline visual field pattern standard deviation (HR, 1.73; 95% CI, 1.56 to 1.91; P < .001), and 1-mm Hg higher mean intraocular pressure during follow-up (HR, 1.11; 95% CI, 1.05 to 1.17; P < .001) were associated with higher risk of developing perimetric glaucoma.
This study found that faster rates of GCIPL and cpRNFL thinning were associated with higher risks of developing perimetric glaucoma. Rates of cpRNFL thinning and specifically GCIPL thinning may be useful measures for monitoring eyes with suspected glaucoma.
在疑似青光眼的眼中,寻找进展为周边视野青光眼的风险的诊断测试具有临床相关性。
调查神经节细胞/内丛状层 (GCIPL) 和周边视网膜神经纤维层 (cpRNFL) 变薄的速率与疑似青光眼眼发展为周边视野青光眼之间的关系。
设计、地点和参与者:本观察性队列研究使用 2021 年 12 月从一个三级中心研究和一个多中心研究中收集的数据。疑似青光眼患者进行了 3.1 年的随访。该研究于 2021 年 12 月设计,并于 2022 年 8 月定稿。
周边视野青光眼的发展定义为连续 3 次出现异常视野结果。使用线性混合效应模型,比较了发展为周边视野青光眼和未发展为周边视野青光眼的疑似青光眼眼中的 GCIPL 变薄率。使用联合纵向多变量生存模型研究了 GCIPL 和 cpRNFL 变薄率在预测发展为周边视野青光眼风险方面的表现。
GCIPL 变薄率和发展为周边视野青光眼的危险比 (HR)。
在总共 462 名参与者中,平均(SD)年龄为 63.3(11.1)岁,275 名患者(60%)为女性。在 658 只眼中,153 只眼(23%)发展为周边视野青光眼。发展为周边视野青光眼的眼的 GCIPL 变薄率更快(最小 GCIPL 变薄的平均速率为-1.28μm/y,而-0.66μm/y;差异,-0.62;95%CI,-1.07 至-0.16;P = .02)。基于联合纵向生存模型,最小 GCIPL 和全球 cpRNFL 变薄的每 1μm/y 更快的速率与发展为周边视野青光眼的风险分别增加 2.4 倍和 1.9 倍(HR,2.4;95%CI,1.8 至 3.2,HR,1.99;95%CI,1.76 至 2.22,分别;P < .001)。在预测因素中,非裔美国人种族(HR,1.56;95%CI,1.05 至 2.34;P = .02)、男性(HR,1.47;95%CI,1.02 至 2.15;P = .03)、基线视野模式标准偏差高 1dB(HR,1.73;95%CI,1.56 至 1.91;P < .001)和随访期间平均眼压高 1mmHg(HR,1.11;95%CI,1.05 至 1.17;P < .001)与发展为周边视野青光眼的风险增加相关。
本研究发现,GCIPL 和 cpRNFL 变薄的速度更快与发展为周边视野青光眼的风险更高相关。cpRNFL 变薄率特别是 GCIPL 变薄率可能是监测疑似青光眼眼的有用指标。